Devsisters corporation (KOSDAQ:194480)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	455,038	299,223	521,268	593,292	1,111,777	144,009
Market Cap Growth	-11.41%	-42.60%	-12.14%	-46.64%	672.02%	98.22%
Enterprise Value	379,629	246,783	469,761	510,418	1,023,661	72,031
Last Close Price	41500.00	27700.00	48500.00	55900.00	104180.62	14229.22
PE Ratio	15.93	10.70	-	-	18.41	-
PS Ratio	1.71	1.27	3.24	2.77	3.01	2.04
PB Ratio	2.68	1.94	3.87	3.27	6.70	1.43
P/TBV Ratio	2.93	2.07	4.14	3.46	7.02	1.44
P/FCF Ratio	12.10	6.77	-	-	17.95	-
P/OCF Ratio	11.66	6.64	-	-	15.71	-
EV/Sales Ratio	1.43	1.05	2.92	2.38	2.77	1.02
EV/EBITDA Ratio	9.98	6.65	-	-	15.96	-
EV/EBIT Ratio	13.45	9.08	-	-	18.07	-
EV/FCF Ratio	10.09	5.59	-	-	16.53	-
Debt / Equity Ratio	0.04	0.05	0.11	0.11	0.10	0.02
Debt / EBITDA Ratio	0.18	0.22	-	-	0.27	-
Debt / FCF Ratio	0.18	0.19	-	-	0.28	-
Asset Turnover	1.02	0.95	0.60	0.75	1.82	0.55
Inventory Turnover	3.85	2.43	0.96	1.10	2.48	0.95
Quick Ratio	3.36	3.18	2.65	5.02	3.39	8.94
Current Ratio	3.66	3.45	3.12	5.78	3.54	9.27
Return on Equity (ROE)	18.32%	19.59%	-31.49%	-3.85%	45.28%	-5.81%
Return on Assets (ROA)	6.80%	6.79%	-11.11%	-4.33%	17.45%	-2.99%
Return on Capital (ROIC)	10.64%	10.91%	-17.13%	-6.47%	24.77%	-3.71%
Return on Capital Employed (ROCE)	12.00%	12.20%	-	-	24.90%	-
Earnings Yield	6.29%	9.35%	-9.52%	-1.13%	5.43%	-4.09%
FCF Yield	8.27%	14.76%	-5.47%	-3.52%	5.57%	-3.63%
Buyback Yield / Dilution	-2.65%	-3.10%	-0.81%	1.16%	-7.52%	-

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.